ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
7,962.30
0.18%
S&P ASX All Technology
3,635.00
0.14%
Brent Oil
69.645
-0.11%
US Dollar vs AUD
1.5852
-0.35%
Bitcoin
79,384.02
-1.49%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. GeoVax Labs Inc (GOVX) Share Price

GeoVax Labs Inc

GeoVax Labs Inc (GOVX)

NASDAQ
1.75
0.04
( 2.34% )
Updated: 01:36:15
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
1.75
Bid
1.75
Offer
1.76
Volume
672,099
1.70 Day's Range 1.885
1.0901 52 Week Range 11.18
Market Cap
16.513M
Previous Close
1.71
Open
1.70
Last Trade
100
@
1.75
Last Trade Time
01:37:01
Financial Volume
US$ 1,204,192
VWAP
1.7917
Average Volume (3m)
658,093
Shares Outstanding
9,436,069
Dividend Yield
-
PE Ratio
-0.66
Earnings Per Share (EPS)
-2.75
Revenue
-
Net Profit
-25.97M

About GeoVax Labs Inc

Geovax Labs Inc is us-based clinical-stage biotechnology company. Geovax Labs Inc is us-based clinical-stage biotechnology company.

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.geovax.com
Headquarters
Wilmington, Delaware, USA
Founded
-
GeoVax Labs Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker GOVX. The last closing price for GeoVax Labs was US$1.71. Over the last year, GeoVax Labs shares have traded in a share price range of US$ 1.0901 to US$ 11.18.

GeoVax Labs currently has 9,436,069 shares in issue. The market capitalisation of GeoVax Labs is US$16.14 million. GeoVax Labs has a price to earnings ratio (PE ratio) of -0.66.

Ask ADVFN Intelligence (AI)

GOVX Latest News

More News

Form 8-K - Current report
Edgar (US Regulatory)
31 August 2024
GOVX (2.34%)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Edgar (US Regulatory)
30 August 2024
GOVX (2.34%)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.052.941176470591.71.8851.4712360491.66329935CS
40.031.744186046511.721.8851.385710251.63594956CS
12-0.625-26.31578947372.3752.751.386580932.00989607CS
26-1.78-50.42492917853.533.881.3811832542.63425942CS
52-0.37-17.45283018872.1211.181.090124258354.38362148CS
156-20.45-92.117117117122.264.51.0901380058724.97473084CS
260-43.25-96.111111111145130.651.0901299488532.45674545CS

GOVX - Frequently Asked Questions (FAQ)

What is the current GeoVax Labs share price?
The current share price of GeoVax Labs is US$ 1.75
How many GeoVax Labs shares are in issue?
GeoVax Labs has 9,436,069 shares in issue
What is the market cap of GeoVax Labs?
The market capitalisation of GeoVax Labs is USD 16.14M
What is the 1 year trading range for GeoVax Labs share price?
GeoVax Labs has traded in the range of US$ 1.0901 to US$ 11.18 during the past year
What is the PE ratio of GeoVax Labs?
The price to earnings ratio of GeoVax Labs is -0.66
What is the reporting currency for GeoVax Labs?
GeoVax Labs reports financial results in USD
What is the latest annual profit for GeoVax Labs?
The latest annual profit of GeoVax Labs is USD -25.97M
What is the registered address of GeoVax Labs?
The registered address for GeoVax Labs is 1209 ORANGE STREET, NEW CASTLE, WILMINGTON, DELAWARE, 19801
What is the GeoVax Labs website address?
The website address for GeoVax Labs is www.geovax.com
Which industry sector does GeoVax Labs operate in?
GeoVax Labs operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
CAPSCapstone Holding Corp
US$ 3.52
(1,308.00%)
43.06k
STSSSharps Technology Inc
US$ 0.5213
(75.70%)
226.91M
RDFNRedfin Corporation
US$ 9.945
(70.88%)
50.59M
SNOASonoma Pharmaceuticals Inc
US$ 3.345
(68.09%)
19.49M
CKPTCheckpoint Therapeutics Inc
US$ 4.055
(64.17%)
28.26M
SXTCChina SXT Pharmaceuticals Inc
US$ 2.87
(-33.46%)
89.37k
ABLVAble View Global Inc
US$ 1.2566
(-27.78%)
474.76k
SUNESUNation Energy Inc
US$ 0.2882
(-27.68%)
9.5M
DSYBig Tree Cloud Holdings Limited
US$ 1.27
(-26.59%)
252.92k
BTOGBit Origin Ltd
US$ 0.4633
(-25.27%)
53.5M
STSSSharps Technology Inc
US$ 0.5295
(78.46%)
227.48M
ICONIcon Energy Corporation
US$ 0.1491
(-11.67%)
83.32M
SPRCSciSparc Ltd
US$ 0.4256
(33.17%)
78.74M
NVDANVIDIA Corporation
US$ 107.95
(-4.21%)
78.36M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 8.6412
(-18.94%)
76.09M

GOVX Discussion

View Posts
tw0122 tw0122 1 week ago
GOVX to the bird flu rescue .. Bird Flu in Cats New Jersey
Two domestic cats in New Jersey have tested positive for the highly pathogenic avian influenza (H5N1) in Hunterdon County. One feral cat developed severe disease, including neurologic signs, and was euthanized. Another indoor-outdoor cat also tested positive, and tests on other cats on the property are pending.Additional Details:Symptoms in Cats: Clinical signs of bird flu in cats can include respiratory signs (discharge from the eyes and mouth, sneezing, coughing, difficulty breathing) and neurologic signs.Transmission: Cats can contract the virus through exposure to infected birds or other animals, contaminated environments, or by consuming raw/undercooked meat or milk from infected sources.Prevention: Pet owners are advised to avoid feeding cats raw milk or meat, avoid contact with sick or dead birds and wildlife, and thoroughly wash hands and change clothes after handling sick animals.Human Risk: While the risk of H5N1 infection to the general population remains low, close contact with infected animals can pose a risk. No human cases have been reported in New Jersey.Reporting: New Jersey residents should contact their veterinarian if they have concerns about their pets. Suspect feline cases should be reported to the New Jersey Department of Health at 609-826-4872 or zoonoticrn@doh.nj.gov.
👍️0
tw0122 tw0122 2 weeks ago
$1.80s after hours with volume. 
👍️0
georgie18 georgie18 4 weeks ago
Nice candle on the close...🥳
👍️0
georgie18 georgie18 4 weeks ago
GOVX...$1.74...🥳...Revresal Candle setting up here...

georgie18

Member Level
Re: None

Monday, January 27, 2025 12:52:55 PM

Post#
672505
of 674217
GOVX...$2.00...Scaling in on the $1.95 Dip...🥳... https://finance.yahoo.com/news/geovax-advanced-mva-manufacturing-process-140000479.html
👍️0
georgie18 georgie18 4 weeks ago
Yup...same here ...🥳
👍️0
tw0122 tw0122 4 weeks ago
Loaded $1.50s buyers finally trickling in having no debt offering fulfilled a few months ago and $500 million in BARDA funding this will fly once again to $10 when the big hedge fund is ready to push it again 
👍️0
georgie18 georgie18 1 month ago
GOVX...$2.00...Scaling in on the $1.95 Dip...🥳... https://finance.yahoo.com/news/geovax-advanced-mva-manufacturing-process-140000479.html
👍 1
tw0122 tw0122 1 month ago
Bottom in low $2s as W pattern established ready for breakout soon. Could mean news 
👍️ 1
tw0122 tw0122 3 months ago
$2.74?Cancer vaccine patent awarded and remember 500 million from other studies being awarded by government low floater 
👍️0
silkman silkman 4 months ago
Bullish?
👍️0
glenn1919 glenn1919 4 months ago
GOVX....................................https://stockcharts.com/h-sc/ui?s=GOVX&p=W&b=5&g=0&id=p86431144783
👍️0
Snoop_dog Snoop_dog 4 months ago
Anyone know if they working on H5N1?
👍️0
PonkenPlonken PonkenPlonken 4 months ago
go go
👍️0
glenn1919 glenn1919 4 months ago
GOVX...................................https://stockcharts.com/h-sc/ui?s=GOVX&p=W&b=5&g=0&id=p86431144783
👍️0
tw0122 tw0122 4 months ago
GOVX $3.57 + 80% kept a few $1.70s. 
👍️0
tw0122 tw0122 4 months ago
GOVX $2.80s + 50%🔥🔥🔥🔥📞🚀🚀🚀🚀
👍 1 🚀 1
tw0122 tw0122 4 months ago
Rockets fired $2.70s + 40% sold most 
👍 1 🚀 1
glenn1919 glenn1919 4 months ago
govx...............................https://stockcharts.com/h-sc/ui?s=GOVX&p=W&b=5&g=0&id=p86431144783
👍 1 🚀 1
tw0122 tw0122 4 months ago
GOVX $1:96 + 1% earnings 11-12
👍️0
tw0122 tw0122 4 months ago
Have plenty of $1.70s financial results Nov 12 afterhours 
👍️0
tw0122 tw0122 5 months ago
Some climbing again 2.26
👍️0
PonkenPlonken PonkenPlonken 5 months ago
crawling out of its hole
keep on watch
👍️0
tw0122 tw0122 5 months ago
GOVX 2.20s offshore hedgies hit some.. The government will also provide around $343M for a clinical research organization to conduct the clinical trial. Under the agreement, BARDA will award GeoVax up to $45M for the manufacturing of clinical materials and support for the Phase 2b study
👍️0
Trompete Trompete 5 months ago
GARBAGE, TRASH, WORTHLESS
👍️0
tw0122 tw0122 5 months ago
$2.07 Offshore hedgies could hit here again but could be a month or two out still
👍️0
tw0122 tw0122 5 months ago
Ok $1.90- $2s flipper
👍️0
tw0122 tw0122 5 months ago
Confirm reversal on candle on 3rd day
👍️0
tw0122 tw0122 6 months ago
Ok ok we see you ..but going to hold $3s this time or another fake out. Support been at $2.60s past few weeks. Looking better
👍️0
tw0122 tw0122 6 months ago
Mpox has spread to at least 14 African countries, including Morocco, which has confirmed its first case in the current outbreak. (Source: BBC Africa)
The Democratic Republic of Congo (DRC) is the epicenter of the outbreak, with over 20,000 cases reported and more than 500 deaths. (Source: WHO)
Neighboring countries, such as Burundi, Kenya, Rwanda, and Uganda, have also reported cases. (Source: WHO)
Vaccination Efforts

The World Health Organization (WHO) recommends use of MVA-BN or LC16 vaccines, or the ACAM2000 vaccine when others are not available. (Source: WHO)
Only people at risk of exposure to mpox should be considered for vaccination, according to WHO. (Source: WHO)
Transmission and Prevention

Mpox is primarily spread through close person-to-person contact with someone who is infected, including through sex. (Source: Nature)
Cleaning and disinfecting surfaces or objects and washing hands after touching contaminated surfaces or objects can help prevent transmission. (Source: WHO)
Avoiding unprotected contact with wild animals, especially those that are sick or dead, and cooking food thoroughly can reduce the risk of getting mpox from animals. (Source: WHO)
Public Health Emergency

The WHO declared the mpox outbreak a Public Health Emergency of International Concern (PHEIC) on August 19, 2024, citing the rapid spread of a new, more transmissible strain of the virus. (Source: WHO)
Research and Development

Scientists are racing to answer questions about the outbreak, including whether vaccines will curb the spread and how the virus is transmitted. (Source: Nature)
👍️ 1
tw0122 tw0122 6 months ago
Looking good bottom about in for hedgies
👍️0
tw0122 tw0122 6 months ago
Watch for 2.52 - .2.92 too hold for flip. 2.08- 2.20 next zone underneath if doesn’t
👍️0
tw0122 tw0122 6 months ago
Hedgies determine new downtrend. New entry as we see $2.80s for another flip
👍️0
tw0122 tw0122 6 months ago
Ok hedgies confirming new upward trend perhaps give it a few hours still
👍️0
tw0122 tw0122 6 months ago
Flip the $3.06 at 3.30s and wait for hedgies to determine direction
👍️0
tw0122 tw0122 6 months ago
Tummies yummy $3.06 bought and then if happens to test next level down add again.
Hedgies want to take it as low as possible before the next big run into Covid vaccine season. Luv you Gary Gensler
👍️0
tw0122 tw0122 6 months ago
Good sign 3.06 hedgies covering shorts now volume picking up 600,000. Almost time to add some more goodies
👍️0
tw0122 tw0122 6 months ago
3.19 zone being tested if holds a few days start adding some again
👍️0
tw0122 tw0122 6 months ago
price of $5.125 per share for expected gross proceeds of $5 million.

4:39 AM EDT, 08/29/2024 (MT Newswires) -- GeoVax Labs (GOVX) said late Wednesday it has agreed to sell 975,610 common shares in a registered direct offering to an institutional investor at a price of $5.125 per share for expected gross proceeds of $5 million.

The company will also issue warrants to purchase up to 975,610 common shares to the investor in a concurrent private placement, it said. The warrants will be exercisable at a price of $5 per share.

Net proceeds will be used for working capital and general corporate purposes, the company said.

The offering is expected to close around Friday, sub
👍️0
tw0122 tw0122 6 months ago
Test 3.19- 3.55 zone wait to confirm before pulling trigger $2.52- 2.92 is the other zone. The hedgies that have most of the shares will determine that as they move this one as they please
👍️0
tw0122 tw0122 6 months ago
Covid flue season blooming still holding a few here but inclined to add some more ..

GeoVax Labs, Inc. is a clinical-stage biotechnology company developing novel vaccines for many of the world’s most threatening infectious diseases and therapies for solid tumor cancers. The company’s lead clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine for which GeoVax was recently awarded a BARDA-funded contract to sponsor a 10,000-participant Phase 2b clinical trial to evaluate the efficacy of GEO-CM04S1 versus an approved COVID-19 vaccine. In addition, GEO-CM04S1 is currently in three Phase 2 clinical trials, being evaluated as (1) a primary vaccine for immunocompromised patients such as those suffering from hematologic cancers and other patient populations for whom the current authorized COVID-19 vaccines are insufficient, (2) a booster vaccine in patients with chronic lymphocytic leukemia (CLL) and (3) a more robust, durable COVID-19 booster among healthy patients who previously received the mRNA vaccines. In oncology the lead clinical program is evaluating a novel oncolytic solid tumor gene-directed therapy, Gedeptin®, in a multicenter Phase 1/2 clinical trial for advanced head and neck cancers. GeoVax has a strong IP portfolio in support of its technologies and product candidates, holding worldwide rights for its technologies and products. The Company has a leadership team who have driven significant value creation across multiple life science companies over the past several decades. For more information about the current status of our clinical trials and other updates, visit our website: www.geovax.com.
👍️0
Gman3343 Gman3343 6 months ago
Going under 2.00 then time to buy.
👍️0
Monksdream Monksdream 6 months ago
GOVX under $5
👍️0
81vette 81vette 6 months ago
Warrents jumped up 100%
👍️0
Biggiee Biggiee 6 months ago
The Fauch knows how to party!
👍️0
Gman3343 Gman3343 6 months ago
Maybe the evil bastard will drop dead .
👍️0
tw0122 tw0122 6 months ago
Buy 6.30s sell $7.30s was todays lesson dip time coming again.. Dr. Fauci Somehow Contracts Ultra-Rare West Nile Virus On Heels Of COVID-19 Infection
👍️0
Gman3343 Gman3343 6 months ago
Good, keep giving that evil idiot all my vaccines and boosters.
He should double up
👍️0
tw0122 tw0122 6 months ago
Catch the dips play next.. Dr. Fauci has COVID again for the third time and has been vaccinated and boosted six times
👍️0
glenn1919 glenn1919 7 months ago
GOVX...............................https://stockcharts.com/h-sc/ui?s=GOVX&p=W&b=5&g=0&id=p86431144783
👍️0
tw0122 tw0122 7 months ago
sale of 1,700,000 shares of the Company’s common stock (or common stock equivalents) at a price of $5.00 per share in a registered direct offering priced above-the-market under Nasdaq rules.
In addition, in a concurrent private placement, the Company will issue to the investor warrants to purchase up to 1,700,000 shares of common stock. The warrants have an exercise price of $5.00 per share, will be exercisable immediately following the date of issuance and will have a term of five years from the date of issuance.
👍️0

Your Recent History

NASDAQ
GOVX
GeoVax Labs
USOTC
PLSH
Panacea Life Sciences (PK)
AQSE
GJGB.GB
VanEck UCITS ETFs
BIT
UB82HL
Unicredit Bank
BIT
UB8LJP
Unicredit Bank
BIT
S28912
Societe Generale Effekten
BIT
F14307
Vontobel Financial Produ...
BIT
W97UD3
UBS
BIT
UC3JQQ
Unicredit Bank
BIT
SISP5S
SG Issuer Societe Generale
BIT
UC4CUV
Unicredit Bank
BIT
UC915L
Unicredit Bank
BIT
F36445
Vontobel Financial Produ...
BIT
RAD
Radici Pietro Industries...
BIT
1K
Kellanova
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads